Hyaluronic Acid – The Ingredient of Choice Hyaluronic acid remains highly preferred dermal fillers agent or ingredient, which accounts for 90% of the total market value. Injected for cosmetic volume improvements, hyaluronic acid (HA) products are garnering robust traction, on the account of being minimally invasive and showing instant results. However, given consideration mounting concerns about some of serious risks associated with HA fillers, innovations are forthcoming for safer formulations and long-lasting fillers. Apart from filling out wrinkles and creases in the patient’s skin, the next wave of HA fillers are also used as Lip fillers for lip augmentations would make skin look airbrushed or eliminate shadows on the face.

North America Maintains Supremacy, Opportunities Abound in APAC North America leads the global adoption of dermal fillers with 50% revenue share. Once a treatment of choice for A-list celebrities, dermal fillers are becoming highly accessible with changing dynamics of beauty. With social media culture shaping new beauty trends and obsession of smooth skin reaching new heights, companies active in the dermal fillers are eyeing opportunities in Asia Pacific. The emergence of China, Japan, and South Korea as the home of the most important beauty markets with regional identities and market realities of the world is leading to realignment of stakeholders’ strategies.

Market Stakeholders to Capitalize on Booming Male Beauty Industry The perception that facial rejuvenation procedures are for women of certain age is on the wane, and positively booming male beauty industry is opening new target audience for companies active in the dermal fillers market. An influx of male consumers or patients in the field of aesthetic restoration, in an attempt to enhance their facial features, is offering tailwinds to growth of the dermal fillers market. However, when it comes to dermal fillers, calls for increased regulations are gaining momentum, thereby compelling companies to invest in bio-remodeling innovation with no added chemicals.

How Growth will Unfold In the current scenario, demand for Hyaluronic acid as well as Non-Hyaluronic acid dermal fillers in the facial aesthetics market is gaining a boost from millennial demographic becoming far more open to filler treatments and growing number of aging population looking for ways to retain their youthful skin. Use of dermal fillers in aesthetic restoration is accounting for relatively high revenue share as compared to application in reconstructive surgery and dentistry. As 7 in 10 units of dermal fillers are used in aesthetic restoration, market players are specifically focused in this category. In addition, numerous advancements in reconstructive surgery is expected to new avenues for market growth in foreseeable future.

FREQUENTLY ASKED QUESTIONS ABOUT DERMAL FILLERS MARKET Which region is expected to lead the dermal fillers market? North America is expected to hold half of the total dermal fillers market share and grow at an impressive growth rate during forecast period. India, China and Japan are anticipated to remain as targeted geographies for leading market players. Which product is expected to have significant demand during the forecast period? Absorbable dermal fillers are expected to hold more than 90% of revenue share in the dermal fillers market owing to its biodegradable properties along with high water retention capacity with maximum binding site offering better clinical outcomes and high level of patient compliance. What are the opportunities provided by emerging countries to key and local players? From an investment point of view, emerging markets can offer high market returns as compared to developed markets for dermal filler. As per the American Society of Plastic Surgeons (ASPS), Brazil hold second largest number for cosmetic procedures with almost 2.3 million procedures in 2018 followed by Mexico (1.0 million), India (0.89 million), and Argentina (0.60 million). Which type of dermal filler is expected to offer significant market growth potential over the next decade? Non-animal origin cross-linked hyaluronic acid has been utilized and proven to be a useful dermal fillers owing due to its safety profile and biodegradable properties. Various manufacturers have invested in developing new and innovative technology for product development, resulting in higher quality fillers that are easier to use and better satisfaction for patients. Which end users are expected to contribute maximum revenue share during the forecast period? Retail pharmacies and drug stores accounted for major revenue share, which constitutes half of total market revenue owing to availability and supply of comprehensive range of dermal fillers, which ensures clinics is fully prepared for all patient for cosmetic and aesthetic medicinal procedures.